Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Other Non-Current Assets of $3.0 million for Q1 2026, up 706.61% year-over-year from $378000.0 in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
Biolife Solutions (BLFS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Other Non-Current Assets for 17 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 706.61% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (up 706.61% YoY), while the FY2025 annual figure was $3.0 million, down 33.46% from the prior year.
- Other Non-Current Assets held at $3.0 million in Q1 2026 per BLFS's latest filing, from $3.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $42.6 million in Q4 2023 and bottomed at $31000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $3.7 million across 5 years, with a median of $319500.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 90.46% — and 2023, when it soared 137441.94%.
- Biolife Solutions' Other Non-Current Assets stood at $31000.0 in 2022, then jumped by 137441.94% to $42.6 million in 2023, then sank by 89.25% to $4.6 million in 2024, then slumped by 33.46% to $3.0 million in 2025, then decreased by 0.03% to $3.0 million in 2026.
- Business Quant data shows BLFS's Other Non-Current Assets at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 3.05 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 378,000.00 |
| Dec 31, 2024 | 4.58 Mn |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 42.64 Mn |
| Sep 30, 2023 | 316,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 256,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | 265,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 452,000.00 |